Description
Identification of therapeutically relevant gene mutations for Cancer
OncQuer TM 500 gene panel (Basic)
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
-
222%
BRCA1 BRCA2 TP53 Gene Testing (Blood) By NGS
Panel of BRCA1&2 Genes
- 263%
- 237%
-
249%
Endopredict
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.